CTEPH - Chronic Thromboembolic Pulmonary Hypertension Thoughts on Di…

Mitral Foundation

R. Martin, A. Anyanwu

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

PERT Consortium 2022

P. Monteleone

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

ACC 2023: Clinical Manifestations of Right Ventricular Failure

ACC 2023 Conference Coverage

J. Huston

Pulmonary Manifestations of SLE: An Update

Keck School of Medicine of USC

F. Quismorio

Pulmonary Arterial Hypertension: Update on Diagnosis and Management

Sandeep Sahay

New Therapies for Pulmonary Venous Hypertension: Updates on the Trea…

Scripps Health

R. C. Mohan

Interventional Treatment Option for CTEPH: Balloon Pulmonary Angiopl…

CHEST 2022 Coverage

G. Heresi

ATS 2023 Insights: Pulmonary Vascular Disease - Clinical Year in Rev…

ATS 2023 Insights

G. Heresi

CHEST 2023 Insights: Pulmonary Hypertension Treatment - How to Start…

CHEST 2023 Insights

J. Elwing

What Is New in 2024 for Pulmonary Embolism

Temple Lung Center

P. Rali

The Social Determinants of Health in Methamphetamine Induced Pulmona…

Brandon Croft

Technical Considerations and Challenges in BPA

The North American Thrombosis Forum (NATF)

R. Bashir

Transition From Acute PE to Chronic Thromboembolic Pulmonary Hyperte…

CTEPH Updates for Community Practitioners

R. Lyn

Sotatercept FDA Approval: A New Dawn in PAH Treatment

Temple Lung Center

A. Raza

Link Between Parenchymal Lung Disease and PH

UCLA Health

R. Saggar

CTEPH Updates for Community Practitioners: The Pitfalls in Diagnosin…

CTEPH Updates for Community Practitioners

G. Heresi

CHEST 2024 Insights: Management of Pulmonary Arterial Hypertension i…

CHEST Annual Meeting Insights

J. Elwing